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Introduction
Multiresistant bacteria (MRB) have become a severe public
health problem, a risk factor for increasing morbibity,
mortality and hospital length of stay and secondarily a
raise of social and health resources consumption. The
Spanish Health System started in 2014 a national cam-
paign (Zero Resistance) conducted to prevent the emerge
of antimicrobial resistance, specially this MRB in intensive
care units (ICUs).
Objectives
To describe the impact of an educational program (Zero
Resistance in ICU) on the incidence of MRB in a ICU hos-
pital of Granada, both in infected and colonized patients,
dividing into extra and intra ICU nosocomial acquisition.
We also describe MRB frequencies and map of resistances.
Methods
An educational campaign recommended by the Spanish
National Health System was driven by the ICU team (phy-
sicians, nurses, assistants...) at the end of the first semester
2014. The program consisted in the implementation of 12
preventive measures (table 1). We realized an observa-
tional study based on ENVIN-HELICS database of the
patients who had MRB positive cultures identifying the
microorganisms at admission (nosocomial extra-ICU) and
after 48 hours of ICU admission (nosocomial intra-ICU),
including infection and colonization, during the year 2014
in our ICU (18 beds). From these results we analyse the
frequencies, before (first semester) and after (second seme-
ster) implementing the campaign.
Results
We had a total of 1005 patients in our ICU in 2014: mean
age 63.40 years CI95(62.4-64.4), 64.88% male, mean
APACHE II 12.84 CI95(12.03-13.62), mean length of stay
5.07 days (SD 8.44). We registered 47 results of MRB cul-
tures: 19 (1.84%) in admission, and 28 (2.71%) after
48 hours in ICU, with a 6.58 ID (for each 1000 days of
stay). 26 were infections and 21 colonizations.
From the total (47), during the first six months of 2014
(were the program started) we registered 27 (4.83%):
11 (2%) in admission and 16 (2.97%) after 48 hours, with a
ID 6.82; 15 infections, 5 (0.93%) in admission and
10 (1.86%) after 48 hours, with a ID 4.26; and 12 coloniza-
tions. In the last semester we registered 20 (4%): 8 (1.61%)
in admission and 12 (2.42%) after 48 hours. From these,
11 were infections, 4 (0.81%) in admission and 7 (1.41%)
after 48 hours, with a ID of 3.67; and 9 colonizations.
The MRB frequency was (including infection and
colonization): MRSA 15.25%, Pseudomona 18.65%, Aci-
netobacter baumanii imipenem-resistant 35%, Entero-
bacteria BLEE 6.45%, GNB carbapenemasa 4%.
Conclusions
The right path it has been achieved as we reached an MRB
Incidence of Density reduction of 13.86% since the imple-
mentation of the Zero Resistance National Program, even
though our incidence of MRB infection and colonization
is still above the standard. Most frequent MRB in our
environment is A. baumanii, and the less frequent is GNB
carbapenemasa.
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